Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer
概览
- 阶段
- 不适用
- 干预措施
- physician assessment
- 疾病 / 适应症
- Head and Neck Cancer
- 发起方
- Centre Oscar Lambret
- 入组人数
- 385
- 试验地点
- 3
- 主要终点
- tobacco consumption
- 状态
- 已完成
- 最后更新
- 上个月
概览
简要总结
This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer
详细描述
Continuing the chronic intoxication by either tobacco or alcohol after the initial diagnosis of a first lung or head and neck cancer significantly improves the risk of experiencing a second cancer, and largely affects the long term survival. Addiction intervention programs should be personalized according to the patient's profile, with the aim to develop more sustained intervention and monitoring in patients identified at higher risk of not spontaneously stopping harmful substance use. As of today, the trajectories of smoking and drinking habits and the risk factors for persisting smoking or drinking habits have been insufficiently explored among patients with a first lung or head and neck cancer. The ALTAK study aims to depict the rate of tobacco smokers 12 months after the initial diagnosis of a first lung or head and neck cancer. The secondary objectives of the study are: * to depict the rate of alcohol users 12 months after the initial diagnosis of a H\&N cancer * to depict the rate of tobacco smokers at cancer diagnosis * to depict the rate of alcohol users at cancer diagnosis * to determine the social, motivational, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping tobacco in the year following the diagnosis of a first TARC. * to determine the social, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping alcohol drinking in the year following the diagnosis of a first H\&N cancer
研究者
入排标准
入选标准
- •first head and neck or lung cancer
- •first support
- •patient covered by health insurance
- •signed informed consent
排除标准
- •prior lung or head and neck cancer
- •History of another cancer \<5 years, not evolutive and untreated at baseline (carcinoma of the cervix, or basal cell carcinoma of the skin properly treated are allowed). The presence of a second discovery tumor location at the same time as the lung or head and neck cancer, is not a criteria for non-inclusion
- •mesothelioma and oesophageal cancer
- •unable to undergo trail medical follow up (geographical, social and psychological reasons)
- •pregnant or nursing women
- •patient under guardianship
研究组 & 干预措施
head and neck or lung cancer
patient with a first head and neck cancer or first lung cancer
干预措施: physician assessment
结局指标
主要结局
tobacco consumption
时间窗: at 12 months
reported tobacco smoking
次要结局
- tobacco smoking(at baseline, 3 and 6 months)
- alcohol drinking(at baseline, 3, 6 and 12 months)
- progression free survival(at 12 months)
- overall survival(at 12 months)
- sociodemographic, cancer-related, tobacco-related, alcohol-related, and psychiatric characteristics(at baseline)